JP4500672B2 - 抗炎症、抗ウイルスおよび抗血栓症活性を有するベンゾイソセレンアゾール誘導体ならびにそれらの使用 - Google Patents

抗炎症、抗ウイルスおよび抗血栓症活性を有するベンゾイソセレンアゾール誘導体ならびにそれらの使用 Download PDF

Info

Publication number
JP4500672B2
JP4500672B2 JP2004503452A JP2004503452A JP4500672B2 JP 4500672 B2 JP4500672 B2 JP 4500672B2 JP 2004503452 A JP2004503452 A JP 2004503452A JP 2004503452 A JP2004503452 A JP 2004503452A JP 4500672 B2 JP4500672 B2 JP 4500672B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
derivative
treatment
general formula
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004503452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519991A5 (enExample
JP2005519991A (ja
Inventor
慧慧 ▲曾▼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Publication of JP2005519991A publication Critical patent/JP2005519991A/ja
Publication of JP2005519991A5 publication Critical patent/JP2005519991A5/ja
Application granted granted Critical
Publication of JP4500672B2 publication Critical patent/JP4500672B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004503452A 2001-06-08 2002-06-10 抗炎症、抗ウイルスおよび抗血栓症活性を有するベンゾイソセレンアゾール誘導体ならびにそれらの使用 Expired - Lifetime JP4500672B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011186666A CN1166651C (zh) 2001-06-08 2001-06-08 具有抗炎和抗肿瘤作用r-双或糖苯丙异硒唑取代化合物
PCT/CN2002/000412 WO2003095436A1 (en) 2001-06-08 2002-06-10 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use

Publications (3)

Publication Number Publication Date
JP2005519991A JP2005519991A (ja) 2005-07-07
JP2005519991A5 JP2005519991A5 (enExample) 2010-03-04
JP4500672B2 true JP4500672B2 (ja) 2010-07-14

Family

ID=4663351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004503452A Expired - Lifetime JP4500672B2 (ja) 2001-06-08 2002-06-10 抗炎症、抗ウイルスおよび抗血栓症活性を有するベンゾイソセレンアゾール誘導体ならびにそれらの使用

Country Status (10)

Country Link
US (2) US7495019B2 (enExample)
EP (1) EP1422225B1 (enExample)
JP (1) JP4500672B2 (enExample)
CN (1) CN1166651C (enExample)
AT (1) ATE540030T1 (enExample)
AU (1) AU2002346271A1 (enExample)
CA (1) CA2450087C (enExample)
ES (1) ES2378983T3 (enExample)
RU (1) RU2324688C2 (enExample)
WO (1) WO2003095436A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820829B2 (en) * 2001-06-08 2010-10-26 Peking University Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
CN100554255C (zh) * 2004-05-31 2009-10-28 北京大学 苯并异硒唑酮衍生物及其制备方法与应用
CN1990475B (zh) * 2005-12-29 2011-09-07 曾慧慧 取代苯并异硒唑酮类化合物及其用途
US20090005422A1 (en) * 2006-05-22 2009-01-01 Thioredoxin Systems Ab Bacterial thioredoxin reductase inhibitors and methods for use thereof
CN101016319B (zh) * 2007-02-13 2010-08-04 中国海洋大学 苯并异硒唑酮氨基糖衍生物及其制备方法和应用
CN101781283B (zh) * 2009-01-16 2014-04-23 凯熙医药（武汉）股份有限公司 硫氧还蛋白还原酶抑制剂化合物及其制备方法和其应用
MD4014C2 (ro) * 2009-04-23 2010-09-30 Татьяна ГУЦУЛ Complecşi polioxometalaţi cu activitate antitumorală
CN101921303A (zh) * 2009-06-09 2010-12-22 曾慧慧 苯并异硒唑酮二氟胞苷类化合物及其制备方法和其用途
CN102453050B (zh) * 2010-11-03 2015-01-07 成都云克药业有限责任公司 一种二膦酸化合物及其制备方法
CA2871535A1 (en) * 2012-01-13 2013-07-18 Celgene Corporation Biomarkers for the treatment of hepatocellular carcinoma
CN103483291B (zh) * 2012-06-14 2015-08-12 沈阳药科大学 4,5-二芳基-1,3-硒唑类化合物及其制备方法和用途
CN104177312B (zh) * 2013-05-27 2018-02-13 黄英武 一种含硒化合物及其医药用途
CN105277699B (zh) * 2014-07-21 2017-05-03 武汉尚宜康健科技有限公司 测试试剂在制备评价临床肿瘤患者临床治疗监测的药品中的应用
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110856717A (zh) * 2018-08-06 2020-03-03 上海元熙医药科技有限公司 一种肿瘤免疫调节剂及其用途
EP3974418B1 (en) 2019-06-24 2025-12-10 Shanghai Yuanxi Medicine Corp. Crystal form of 1,4-[bis(1,2-benzisoselenazol-3(2h)-one)]butane, preparation method therefor, and application thereof
WO2023277584A1 (ko) * 2021-06-29 2023-01-05 (주)라이프신약 셀레늄 화합물을 유효성분으로 포함하는 노화세포 제거용 조성물
KR20230002109A (ko) * 2021-06-29 2023-01-05 (주)라이프신약 셀레늄 화합물을 유효성분으로 포함하는 노화세포 제거용 조성물
CN116891443B (zh) * 2023-09-08 2023-12-01 潍坊医学院 一种异吲哚-1-酮衍生物及其制备方法、应用
WO2025169231A1 (en) * 2024-02-09 2025-08-14 Indian Institute Of Science Organoselenium compounds, preparation and implementations thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027075A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
DE3226284A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0198277B1 (de) * 1985-04-12 1989-05-03 A. Nattermann & Cie. GmbH Diselenobis-benzoesäureamide primärer und sekundärer Amine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0199986B1 (de) * 1985-04-27 1990-04-25 A. Nattermann & Cie. GmbH Neue Benzisoselenazolonyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DE3827093A1 (de) * 1988-08-10 1990-02-15 Nattermann A & Cie Verfahren zur herstellung von hochreinem ebselen
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE4445966A1 (de) * 1994-12-22 1996-06-27 Agfa Gevaert Ag Fotografisches Silberhalogenidmaterial
CN1110489C (zh) * 1998-11-11 2003-06-04 中国医学科学院药物研究所 苯并异硒唑酮磺酰胺衍生物及其制法和其在制备药物中的应用
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer

Also Published As

Publication number Publication date
AU2002346271A1 (en) 2003-11-11
CA2450087A1 (en) 2003-11-20
US20090117204A1 (en) 2009-05-07
RU2003134946A (ru) 2005-06-10
ES2378983T3 (es) 2012-04-19
ATE540030T1 (de) 2012-01-15
RU2324688C2 (ru) 2008-05-20
US8609702B2 (en) 2013-12-17
WO2003095436A1 (en) 2003-11-20
JP2005519991A (ja) 2005-07-07
US7495019B2 (en) 2009-02-24
CN1390837A (zh) 2003-01-15
EP1422225B1 (en) 2012-01-04
CA2450087C (en) 2012-08-07
CN1166651C (zh) 2004-09-15
EP1422225A1 (en) 2004-05-26
US20050014801A1 (en) 2005-01-20
EP1422225A4 (en) 2004-10-20

Similar Documents

Publication Publication Date Title
JP4500672B2 (ja) 抗炎症、抗ウイルスおよび抗血栓症活性を有するベンゾイソセレンアゾール誘導体ならびにそれらの使用
JP5216083B2 (ja) アザインドール−インドールカップリング誘導体及びその調合と用途
JP2017078081A (ja) 四環系アントラキノン誘導体
RU2120939C1 (ru) 6-[x-(2-гидроксиэтил)аминоалкил]-5,11-диоксо-5,6-дигидро-11h-инде- но/1,2-с/изохинолины или их соли с неорганическими и органическими кислотами, способы их получения и фармацевтическая композиция на их основе
HUT67899A (en) Thioxanthenone antitumor agents
ES2198580T3 (es) Nuevas sales de compuestos anionicos de ru (iii), utilizados como agentes antimetastasicos y antineoplasticos.
US7820829B2 (en) Bisbenzisoselenazolonyl derivatives having antineoplastic, anti-inflammatory and antithrombotic activities as well as their use
JPH06506226A (ja) 抗ガン剤としてのアミドおよびチオアミドリンカー含有のビス−ナフタルイミド類
KR101876750B1 (ko) 신규한 2-아민 치환 1,4-나프토퀴논 화합물 및 이를 포함하는 암의 예방 또는 치료용 약제학적 조성물
TW202412813A (zh) 含硒元素的查爾酮化合物及其製備方法、包含其的醫藥組合物、以及用於製備預防或治療大腸癌之醫藥組合物的用途
TWI308569B (en) Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
CN108101943A (zh) 一种替诺福韦前药或可药用盐及其在医药上的应用
CN115260107B (zh) 一种抗肿瘤药物前药、药物组合物及在肿瘤靶向治疗领域的应用
CN112442062B (zh) 一种柳胺酚有机硅化合物及抗肿瘤用途
JPS62167744A (ja) 弗素化ジアミノアルキン誘導体
KR102547925B1 (ko) 암 치료를 위한 치료제로서의 4-옥소-n-(4-히드록시페닐)레틴아미드 유도체
US6921824B1 (en) Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
CN118638059A (zh) FXIa抑制剂化合物的多晶型及其制备方法和医药用途
CN112300187A (zh) 一种斑蝥素衍生物、其药物组合物及其应用
HK1239656B (en) 4-oxo-n-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer
JPS6270376A (ja) ジスルフイド化合物及び抗腫瘍剤
CN103804427A (zh) 一种芳基伯胺钌配合物、制备方法及其用途

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050608

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091228

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20091228

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100406

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100419

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130423

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4500672

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140423

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term